AMG 479

· NantCell, Inc.

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for AMG 479, covering 2013-07-18 to 2024-10-17. Get the full timeline:

Most recent: Clinical Trial Update: QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer [Phase 1, Phase 2]

See pricing